Type I interferons keep activated T cells alive

被引:629
|
作者
Marrack, P
Kappler, J
Mitchell, T
机构
[1] Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Dept Med, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Biochem Biophys & Genet, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA
[5] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1999年 / 189卷 / 03期
关键词
interferon gamma; apoptosis; interferon type I; cell survival; T cell;
D O I
10.1084/jem.189.3.521
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigen injection into animals causes antigen-specific T cells to become activated and, rapidly thereafter, die. This antigen-induced death is inhibited by inflammation. To find out how inflammation has this effect, various cytokines were tested for their ability to interfere with the rapid death of activated T cells. T cells were activated in vivo, isolated, and cultured with the test reagents. Two groups of cytokines were active, members of the interleukin 2 family and the interferons (IFNs) alpha and beta. This activity of IFN-alpha/beta has not been described previously. It was due to direct effects of the IFNs on the T cells and was not mediated by induction of a second cytokine such as interleukin 15. IFN-gamma did not slow the death of activated T cells, and therefore the activity of IFN-alpha/beta was not mediated only by activation of Stat 1, a protein that is affected by both classes of IFN. IFN-alpha/beta did not raise the levels of Bcl-2 or Bcl-(XL) in T cells. Therefore, their activity was distinct from that of members of the interleukin 2 family or CD28 engagement. Since IFN-alpha/beta are very efficiently generated in response to viral and bacterial infections, these molecules may be among the signals that the immune system uses to prevent activated T cell death during infections.
引用
收藏
页码:521 / 529
页数:9
相关论文
共 50 条
  • [41] Adjuvant activity of type I interferons
    Tovey, Michael G.
    Lallemand, Christophe
    Thyphronitis, George
    BIOLOGICAL CHEMISTRY, 2008, 389 (05) : 541 - 545
  • [42] Type I interferons in host defense
    Stetson, Daniel B.
    Medzhitov, Ruslan
    IMMUNITY, 2006, 25 (03) : 373 - 381
  • [43] Type I interferons in systemic autoimmunity
    Sozzani, Silvano
    Bosisio, Daniela
    Scarsi, Mirko
    Tincani, Angela
    AUTOIMMUNITY, 2010, 43 (03) : 196 - 203
  • [44] Type I interferons (α/β) in immunity and autoimmunity
    Theofilopoulos, AN
    Baccala, R
    Beutler, B
    Kono, DH
    ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 : 307 - 336
  • [45] Type I interferons: expression and signalization
    J. Doly
    A. Civas
    S. Navarro
    G. Uze
    Cellular and Molecular Life Sciences CMLS, 1998, 54 : 1109 - 1121
  • [46] Overview of the biology of type I interferons
    Kalliolias, George D.
    Ivashkiv, Lionel B.
    ARTHRITIS RESEARCH & THERAPY, 2010, 12
  • [47] Overview of the biology of type I interferons
    George D Kalliolias
    Lionel B Ivashkiv
    Arthritis Research & Therapy, 12
  • [48] Induction of type I interferons by bacteria
    Monroe, Kathryn M.
    McWhirter, Sarah M.
    Vance, Russell E.
    CELLULAR MICROBIOLOGY, 2010, 12 (07) : 881 - 890
  • [49] Type I interferons in anticancer immunity
    Zitvogel, Laurence
    Galluzzi, Lorenzo
    Kepp, Oliver
    Smyth, Mark J.
    Kroemer, Guido
    NATURE REVIEWS IMMUNOLOGY, 2015, 15 (07) : 405 - 414
  • [50] Signal transduction by type I interferons
    David, M
    BIOTECHNIQUES, 2002, : 58 - 65